Floating drug delivery systems are the gastroretentive forms that precisely control the release rate of target drug to a spec ific site which facilitate an enormous impact on health care. The purpose of this research was to develop a novel gastro retentive drug delivery system based on direct compression method for sustained delivery of active agent to improve the bioavailability, reduce the number of doses and to increase patient compliance. Gastro retentive floating tablets of Prochlorperazine dimaleate (PCZ) were prepared by direct compression method using altered concentrations of HPMC K4, HPMC K15 and PVP K30 as polymers. The prepared tablets of PCZ were evaluated for hardness, thickness, friability, weight variation, drug content uniformity, buoyancy lag time, total floating time, in-vitro dissolution study, etc. All the compositions were resulted in adequate Pharmacopoeial limits. Compatibility studies was execution during FTIR shown that there was absence of probable chemical interaction between pure drug and excipients. The varying concentration of gas generating agent and polymers was fou nd to affect on in-vitro drug release and floating lag time. In vitro drug release of floating gastro retentive tablet of PCZ shown that the formulation F9 was found to be the best formulation as it releases 98.89% in a controlled manner for an extended period of time (up to 12 hrs). The release data was fitted to various mathematical models such as Higuchi, Korsmeyer-Peppas, First order and Zero order to evaluate the kinetics and mechanism of the drug release. The optimized formulation (F9) showed no significant change in physical appearance, drug content, floating lag time, in vitro dissolution studies after 75%±5% RH at 40±20C relative humidity for 6 months. Prepared floating tablets of PCZ may prove to be a potential candidate for safe and effective controlled drug delivery over an extended period of time for gastro retentive dr ug delivery system.
INTRODUCTION
The oral route is considered as the most promising route of drug delivery. Drugs with narrow absorption window in the GIT have poor absorption 1 . Therefore, Grdds have been developed, which prolong gastric emptying time of drug and offers numerous advantages; improves bioavailability, reduces drug waste and improves solubility for drugs that are less soluble in a high pH environment of small intestine 2 . To formulate a successful stomach specific or gastroretentive drug delivery system, several techniques are currently used such as HBS or floating drug delivery systems, low density systems, raftsystems, incorporating alginate gels, bioadhesive or mucoadhesive systems, super porous hydrogels and magnetic systems. Swellable, floating and SR tablets are developed by using a combination of hydrophilic polymers (HPMC), swelling agents (crosspovidone and crosscarmellose sodium) and effervescent substances (NaHCO 3 and citric acid). Prochlorperazine dimaleate (also known as Prochlorperazin, Compazine, Capazine, Stemetil), the dimaleate salt of Prochlorperazine, is a dopamine (D2) receptor antagonist that belongs to the phenothiazine class of antipsychotic agents that are used for the antiemetic treatment of nausea and vertigo. It is also a highly potent typical antipsychotic, 10-20 times more potent than chlorpromazine. Prochlorperazine dimaleate is also used to treat migraine headaches. The objective of the present research work was to provide gastroretentive formulation that will provide once daily, sustained release dosage form of PCZ 3 .
MATERIALS AND METHODS

Materials
Prochlorperazine dimaleate was purchased from Sigma Aldrich-Merck, Bengaluru, Karnataka, India. Hydroxypropyl methylcellulose (HPMC K4M, HPMC K15M) was procured from Meditab Specialities Pvt. Ltd., Satara. PVP K30 was purchased from S.D fine chemicals, Mumbai. Sodium bicarbonate, Citric acid, magnesium stearate, talc were purchased from Mapromax, Life sciences Pvt. Ltd., Dehradun. Other solvents and chemicals used in the research were of LR grade. All the studies were carried in distilled water.
Methods
Preformulation studies
Standardization of PCZ by UV-Visible spectrophotometry
Accurately weighed 10 mg of drug was dissolved in 10 ml of 0.1 N HCl solutions in 10 ml of volumetric flask. The resulted solution 1000µg/ml and from this solution 1 ml pipette out and transfer into 10 ml volumetric flask and volume make up with 0.1 N HCl solution and prepare suitable dilution to make it to a concentration range of 2-10μg/ml. The spectrum of this solution was run in 200-400 nm range in U.V. spectrophotometer (Labindia-3000+).
Fourier transform infrared (FTIR) spectroscopy
The physical properties of the physical assortment were comparing with those of lafutidine pure drug. Samples was assorted comprehensively through 100mg potassium bromide IR powder as well as compacted under vacuum at a pressure of concerning 12 psi for 3 minutes. The ensuing disc was mounted in an appropriate holder in Brukers Alpha IR spectrophotometer and the IR spectrum was recorded from 3500 cm to 500 cm. The resultant spectrum was compared for any spectrum changes.
Pre compression evaluation
Flow properties and compressibility properties of powder mixture were evaluated by measurement of angle of repose, bulk density, tapped density, carr's index, and hausner ratio.
Angle of repose (θ)
The angle of repose was determined by using fixed funnel method. The physical mixtures of drug with different excipients were prepared and the accurately weighed drug powder or its physical mixture was taken in a funnel. The height of the funnel was adjusted in such a way that the tip of the funnel just touches the apex of the heap of the drug powder. The powder was allowed to flow through the funnel freely onto surface. The angle of repose was calculated using the following equation.
θ = tan-1(h/r)
Where, h and r are the height and radius of the powder cone respectively.
Bulk density
Both loose bulk density (LBD) and tapped density (TBD) were determined were calculated using the following formulas. LBD = Powder weight/volume of the packing TBD = Powder weight /tapped volume of the packing
Compressibility index
The compressibility index of the granules was determined by Carr's compressibility index.
Carr's index (%) = [(TBD -LBD)/TBD] × 100.
Hausner's ratio
Hausner's ratio is an indirect index of ease of measuring the powder flow. It was calculated by the following formula 4-6 .
Hausner's ratio = Tapped density/Bulk density.
Formulation development of tablets
Direct compression method
Different tablets formulations (F1-F9) were prepared by direct compression technique. All powders were passed through 40 meshes. Required quantities of drug and polymers were mixed thoroughly Magnesium stearate was added as lubricant. Talc was used as glidant. Lactose was used as diluents. Finally the powder mix was subjected to compression after mixing uniformly in a polybag. Prior to compression, the blends were evaluated for several tests 7 . The composition of PCZ floating tablets was shown in Table  1 .
Table 1 Formulation composition of PCZ gastro retentive tablets
Evaluation of tablets
All the tablets were evaluated for following different parameters which includes;
General appearance
Five tablets from different batches were randomly selected and organoleptic properties such as color, odor, taste, shape were evaluated. Appearance was judged visually.
Thickness and diameter
Thickness and diameter of tablets were determined using Vernier caliper. Five tablets from each batch were used, and an average value was calculated.
Hardness
For each formulation, the hardness of five tablets was determined using the Monsanto hardness tester (Cadmach). 
Excipients
Friability
The friability of a sample of 10 tablets was measured using a Friability tester (Electro Lab).Ten tablets were weighed, rotated at 25 rpm for 4 minutes. Tablets were reweighed after removal of fines (dedusted) and the percentage of weight loss was calculated.
Uniformity of weight
Twenty tablets were randomly selected from each batch individually weighed, the average weight and standard deviation of 20 tablets was calculated.
Drug content
Twenty tablets were taken and amount of drug present in each tablet was determined. The tablets were crushed in a mortar and the powder equivalent to 100mg of drug was transferred to 100ml standard flask. The powder was dissolved in 50 ml of 0.1 N HCl and made up to volume with of 0.1 N HCl. The sample was mixed thoroughly and filtered through a 0.45μ membrane filter. The filtered solution was diluted suitably and analyzed for drug content by UV spectrophotometer at a λmax of 256 nm using of 0.1 N HCl as blank.
In vitro buoyancy studies
In vitro buoyancy was determined by floating lag time as per the method described by Rosa et al 8 . The tablets were separately in a 100 ml glass beaker containing simulated gastric fluid (SGF), pH 1.2 as per USP. The time necessary for the tablet to increase to the outside and float was determined as floating lag time. The experiments were conducted in triplicate. Total floating times were measured during in vitro dissolution studies.
Dissolution rate studies
In vitro drug release of the sample was done using USP-type II dissolution apparatus (Paddle type). The dissolution medium, 900 ml 0.1N HCl was set into the dissolution flask maintaining the temperature of 37±0.5 0 c and rpm of 75. One PCZ tablet was set in every container of dissolution apparatus. The mechanical assembly was permitted to keep running for 10 hours. Sample measuring 5 ml were pulled back after each 1 hour up to 10 hours using 10ml pipette.
The new disintegration medium (37 0 C) was supplanted each time with a similar amount of the sample and takes the absorbance at 256 nm using spectroscopy [9] [10] [11] .
Mathematical treatment of in-vitro release data:
The quantitative analysis of the qualities got in dissolution/release tests is simpler when mathematical formulas that express the dissolution comes about as an element of a portion of the measurement frames attributes are utilized.
Zero-order kinetics:
The pharmaceutical dosage frames following this profile release a similar measure of medication by unit of time and it is the ideal method of medication release keeping in mind the end goal to accomplish a pharmacological prolonged action. The following relation can, in a simple way, express this model:
Qt = Qo + Ko t
where Qt is the amount of drug dissolved in time t, Qo is the initial amount of drug in the solution (most times, Qo=0) and Ko is the zero order release constant.
First-order kinetics: The following relation expresses this model:
where Qt is the amount of drug dissolved in time t, Qo is the initial amount of drug in the solution and K1 is the zero order release constant.
Along these lines a graphic of the decimal logarithm of the released measure of drug versus time will be linear. The pharmaceutical dosage shapes following this dissolution profile, for example, those containing water-solvent drugs in permeable frameworks, discharge drug in a way that is corresponding to the measure of drug staying in its inside, in such way, that the measure of drug released by unit of time reduce. where Mt/M  is fraction of drug released, a is kinetic constant, t is release time and n is the diffusional exponent for drug release. 'n' is the slope value of log Mt/M  versus log time curve. Peppas stated that the above equation could adequately describe the release of solutes from slabs, spheres, cylinders and discs, regardless of the release mechanism. Peppas used this n value in order to characterize different release mechanisms, concluding for values for a slab, of n =0.5 for fickian diffusion and higher values of n, between 0.5 and 1.0, or n =1.0, for mass transfer following a non-fickian model. In case of a cylinder n =0.45 instead of 0.5, and 0.89 instead of 1.0. This equation can only be used in systems with a drug diffusion coefficient fairly concentration independent. To the determination of the exponent n the portion of the release curve where Mt/M  < 0.6 should only be used. To use this equation it is also necessary that release occurs in a one-dimensional way and that the system widththickness or length-thickness relation be at least 10. In the absence of lag time or burst effect, l and b value would be zero and only at n is used. This mathematical model, also known as Power Law, has been used very frequently to describe release from several different pharmaceutical modified release dosage forms [12] [13] [14] .
Stability studies
The optimized formulation of PCZ were packed in strips of 0.04 mm thick aluminum foil laminated with poly vinyl chloride by strip packing and these packed formulations were stored in ICH certified stability chambers (Thermo labs, Mumbai) maintained at 40 0C and 75% RH for 6 months. The samples were withdrawn periodically and evaluated for their floating lag time, content uniformity and for in vitro drug release.
RESULTS AND DISCUSSION
The λ max of PCZ was found to be 256 nm by using U.V. spectrophotometer (Labindia-3000+) in linearity range 2-10µg/ml Figure1, 2. Identification of betahistine was done by FTIR spectroscopy with respect to marker compound. It was identified from the result of IR spectrum as per specification. Tablet powder blend was subjected to various preformulation parameters Table 2 . The angle of repose values indicates that the powder blend has good flow properties. The bulk density and tapped density of all the formulations was found to be in the range of 0.349to 0.365 (gm/ml) and 0.438 to0.485 showing that the powder has good flow properties. The compressibility index of all the formulations was found to be ranging between 20.320 to 26.186which shows that the powder has good flow properties. All the formulations have shown the Hauser's ratio ranging between 1.255to 1.355indicating the powder has good flow properties. PCZ tablet quality control tests such as weight variation, hardness and friability, thickness, drug content and drug release studies in different media were performed on the compression tablet. All the parameters such as weight variation, hardness, friability, thickness and drug content were found to be within limits Table 3 . In the present study 9 formulations with variable concentration of polymers (HPMC K4, K 15) were prepared by direct compression method and evaluated for physicochemical properties. The results of buoyancy lag time, total floating time and in vitro drug release was given in Table 4 , 5 & Fig.3 . The results indicated that optimizes formulation F9 on immersion in 0.1N HCl at 37±0.5 0 C tablets immediately and remain buoyant up to 12hr without disintegration. These 2 factors are essential for tablets to acquire density< 1, so that it remains buoyant on the gastric fluids. The in vitro drug release data of the optimized formulation was subjected to goodness of fit test by linear regression analysis according to zero order, first order kinetic equation, higuchi's and korsmeyer's models in order to determine the mechanism of drug release. When the regression coefficient values of were compared, it was observed that 'r' values of Korsmeyer Peppas was maximum i.e. 0.977 hence indicating drug release from formulations was found to follow Korsmeyer Peppas model. Table 6 , 7 & Fig. 4-7 . 3 In-vitro drug release study of GRF tablets 
